{"title":"Epigenetics: the link between environmental exposures and autoimmune diseases","authors":"Wenhui Zhou , Bo Zhang , Ming Zhao , Qianjin Lu","doi":"10.1016/j.coi.2025.102592","DOIUrl":null,"url":null,"abstract":"<div><div>Autoimmune diseases (AIDs) comprise a highly heterogeneous group of disorders with significant morbidity, disability, and mortality. Growing scientific evidence has suggested the interactions between genetic and environmental factors robustly involving in the pathogenesis of AIDs. Epigenetics serves as a critical bridge linking between gene expression patterns and external environmental stimuli. Several research areas have emerged to investigate these epigenetic modifications, including DNA methylation, histone modifications, and microRNAs. On the other hand, epidemiological studies have well-established the marked relationship between the occurrence and development of AIDs and environmental exposures, especially chemical, physical, and biologic factors. However, the knowledge gap between the role of specific external agents in the development of AIDs and the impact of epigenetic signatures has not been filled. This review synthesizes recent findings AID-associated environmental factors, their role in the development of AIDs, and their interactions with genetics and influence on epigenetic modifications. We also discuss the tool for assessing causal relationships between environmental risks and clinical intervention trials to prevent disease progression. In all, precise understanding of the underlying mechanisms between epigenetics and environmental risk factors is crucial for timely prevention and treatment to improve AIDs outcomes.</div></div>","PeriodicalId":11361,"journal":{"name":"Current Opinion in Immunology","volume":"95 ","pages":"Article 102592"},"PeriodicalIF":6.6000,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0952791525000688","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Autoimmune diseases (AIDs) comprise a highly heterogeneous group of disorders with significant morbidity, disability, and mortality. Growing scientific evidence has suggested the interactions between genetic and environmental factors robustly involving in the pathogenesis of AIDs. Epigenetics serves as a critical bridge linking between gene expression patterns and external environmental stimuli. Several research areas have emerged to investigate these epigenetic modifications, including DNA methylation, histone modifications, and microRNAs. On the other hand, epidemiological studies have well-established the marked relationship between the occurrence and development of AIDs and environmental exposures, especially chemical, physical, and biologic factors. However, the knowledge gap between the role of specific external agents in the development of AIDs and the impact of epigenetic signatures has not been filled. This review synthesizes recent findings AID-associated environmental factors, their role in the development of AIDs, and their interactions with genetics and influence on epigenetic modifications. We also discuss the tool for assessing causal relationships between environmental risks and clinical intervention trials to prevent disease progression. In all, precise understanding of the underlying mechanisms between epigenetics and environmental risk factors is crucial for timely prevention and treatment to improve AIDs outcomes.
期刊介绍:
Current Opinion in Immunology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.
In Current Opinion in Immunology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.
Current Opinion in Immunology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.
Current Opinion in Immunology builds on Elsevier''s reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Immunology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists'' workflow.